Cognition Therapeutics Publishes Eeg Findings From Phase 2 Sequel Study of Ct1812 in Mild-to-Moderate Alzheimer’s Disease
Cognition Therapeutics發佈了CT1812在輕至中度阿爾茨海默病第2期後續研究的EEG結果
Cognition Therapeutics Publishes Eeg Findings From Phase 2 Sequel Study of Ct1812 in Mild-to-Moderate Alzheimer’s Disease
Cognition Therapeutics發佈了CT1812在輕至中度阿爾茨海默病第2期後續研究的EEG結果
譯文內容由第三人軟體翻譯。